Stem Cell Research & Therapy, 2023 · DOI: https://doi.org/10.1186/s13287-023-03395-4 · Published: June 2, 2023
Ependymal cells, a dormant population of ciliated progenitors found within the central canal of the spinal cord, undergo significant alterations after spinal cord injury (SCI). Understanding the molecular events that induce ependymal cell activation after SCI represents the first step toward controlling the response of the endogenous regenerative machinery in damaged tissues. A more complete understanding of the role and function of individual signaling pathways in endogenous spinal cord progenitors may foster the development of novel targeted therapies to induce the regeneration of the injured spinal cord.
Understanding signaling pathways in spinal cord progenitors may foster development of novel targeted therapies.
Enhancing the neurogenic potential of ependymal cells or modifying the microenvironment represents an attractive strategy in SCI-focused regenerative medicine.
Pharmacological intervention to control the activation of the resident stem cells in the spinal cord represents a significant challenge to developing safe and efficient SCI repair/regeneration strategies.